MHRA Drug Safety Update December 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 5 December 2021) has been published and includes articles on:

  • Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
  • Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS)
  • Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
  • COVID-19 vaccines and medicines: updates for December 2021
  • Letters and medicine recalls sent to healthcare professionals in November 2021

To see the latest MHRA Drug Safety Updates in full, visit the website

Help us raise awareness about the challenges the community pharmacy sector is facing by inviting your MP to attend our winter pressures event.

Click Here